Supraja Sama
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
-
- Diabetes Treatment and Management
Papers in
-
- Cardiovascular and Diving-Related Complications 1
-
- Chemotherapy-induced cardiotoxicity and mitigation 2
- Co-authors
- Tomas G. Neilan (6 shared papers)Zsófia D. Drobni (4 shared papers)Hannah Gilman (6 shared papers)Carlos A. Gongora (4 shared papers)Daniel A. Zlotoff (3 shared papers)Giselle Alexandra Suero‐Abreu (3 shared papers)J. R. Barnes (1 shared paper)Jingyi Gong (1 shared paper)
- Journals
- JACC Heart Failure (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Cancers (1 paper)International Journal of Cardiology (1 paper)
- Partner nations
- United StatesHungaryAustralia
In The Last Decade
Supraja Sama
5 papers receiving 165 citations
Peers
Comparison fields: 5 of 36
- Cardiology and Cardiovascular Medicine 92
- Endocrinology, Diabetes and Metabolism 44
- Oncology 64
- Pulmonary and Respiratory Medicine 45
- Cancer Research 16
Countries citing papers authored by Supraja Sama
This map shows the geographic impact of Supraja Sama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Supraja Sama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Supraja Sama more than expected).
Fields of papers citing papers by Supraja Sama
This network shows the impact of papers produced by Supraja Sama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Supraja Sama. The network helps show where Supraja Sama may publish in the future.
Co-authors
The 25 scholars most cited alongside Supraja Sama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 97 | |
| 2 | 2023 | 31 | |
| 3 | 2022 | 28 | |
| 4 | 2022 | 10 | |
| 5 | 2022 | 3 | |
| 6 | 2025 | 0 |
About Supraja Sama
Supraja Sama is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism, having authored 6 papers that have together received 169 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cardiac Imaging and Diagnostics (2 papers), Cardiovascular and Diving-Related Complications (1 paper), Metabolism, Diabetes, and Cancer (1 paper), Neuroscience of respiration and sleep (1 paper), Diabetes Treatment and Management (1 paper) and Inflammatory Biomarkers in Disease Prognosis (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (92 citations), Endocrinology, Diabetes and Metabolism (44 citations), Oncology (64 citations), Pulmonary and Respiratory Medicine (45 citations) and Cancer Research (16 citations). Supraja Sama has collaborated with scholars based in United States, Hungary and Australia. Frequent co-authors include Tomas G. Neilan, Zsófia D. Drobni, Hannah Gilman, Carlos A. Gongora, Daniel A. Zlotoff, Giselle Alexandra Suero‐Abreu, J. R. Barnes, Jingyi Gong, Jeremy S. Abramson and Amna Zafar. Their work appears in journals such as JACC Heart Failure, International Journal of Radiation Oncology*Biology*Physics, Journal for ImmunoTherapy of Cancer, Cancers and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.